JPRN-UMIN000036437招募中未知
JALSG AML/MDS/CMML Clinical Observational Study(JALSG-CS-11-MDS-SCT) - JALSG AML/MDS/CMML Clinical Observational Study(JALSG-CS-11-MDS-SCT)
Japan Adult Leukemia Study Group(JALSG)0 个研究点目标入组 491 人开始时间: 2019年4月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 491
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
JALSG AML/MDS/CMML Clinical Observational Study (JALSG-CS)-17AML(acute myeloid leukemia and related neoplasms),MDS(myelodysplastic syndromes),CMML(chronic myelomonocytic leukemia)JPRN-UMIN000027961Japan Adult Leukemia Study Group (JALSG)6,542
终止
2 期
Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPYMyelodysplastic Syndrome (MDS)Acute Myeloid Leukemia (AML)NCT02992860GWT-TUD GmbH25
进行中（未招募）
不适用
A pilot study to assess whether mutations detected in baseline marginal zone lymphoma are predictive of resistance to bruton tyrosine kinase (BTK) inhibition.LymphomaACTRN12619000024145Australasian Leukaemia and Lymphoma Group21
Unknown
3 期
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years OldAcute Myeloid LeukemiaNCT03257241Polish Adult Leukemia Group582
已完成
2 期
Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5MDSAMLNCT00761449Nordic MDS Group28